ClinicalTrials.gov
public full text
Public Domain
Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection
This randomized, double blind, placebo controlled study aims to establish the impact of the oral supplement, Immulina TM, on enhancing host resilience to the effects of viral influenza infection in humans.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Spirulina Supplementation In Recovery From Damaging Exercise#866560
- Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension#1008822
- Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge#675922
- Weight-Loss Cutoff for Mortality in Mice Impacts the Results From Combination Drug Therapy for an Influenza A H1N1pdm Virus Infection#224099
- Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine#429616
Record · ID 1045839
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive